Table 2.
Stratified Survival Analysis by Socio-demographic Characteristics (n=60)
| Variable | SF | 95% CI | p-value |
|---|---|---|---|
| Overall survival | 84.3 | 58.1–94.7 | |
| Sex | 0.10 | ||
| Female | 88.8 | 43.3–92.3 | |
| Male | 79.5 | 39.5–94.5 | |
| Age, years | 0.05 | ||
| 18–64 | 90.0 | 70.8–96.8 | |
| ≥65 | 50.0 | 60.0–91.0 | |
| Disease group* | 0.01 | ||
| Leukemia | 60.8 | 17.6–86.7 | |
| Lymphoma | 1.00 | - | |
| Myeloma | 1.00 | - | |
| Disease stage | 0.17 | ||
| Early | 1.00 | - | |
| Late | 77.2 | 43.3–92.3 | |
| Fever | 0.02 | ||
| Yes | 62.6 | 18.1–87.9 | |
| No | 1.00 | - | |
| Splenomegaly | 0.71 | ||
| Yes | 96.0 | 74.8–99.4 | |
| No | 78.8 | 43.0–93.5 | |
| Hepatomegaly | 0.54 | ||
| Yes | 88.2 | 59.0–97.1 | |
| No | 81.6 | 41.9–95.3 | |
| Lymphadenopathy | 0.71 | ||
| Yes | 87.6 | 65.1–96.0 | |
| No | 75.0 | 12.7–96.0 | |
| Abdominal mass | 0.65 | ||
| Yes | 91.6 | 53.9–98.7 | |
| No | 82.5 | 51.1–94.6 | |
| HIV status | 0.87 | ||
| Positive | 1.00 | - | |
| Negative | 87.4 | 64.9–95.9 | |
| Unknown | 66.6 | 54.1–94.5 | |
| Anaemia | 0.86 | ||
| Yes | 86.2 | 54.6–96.4 | |
| No | 82.6 | 37.7–96.3 | |
| Thrombocytopaenia | 0.43 | ||
| Yes | 66.6 | 5.4–94.5 | |
| No | 86.0 | 56.2–96.3 | |
| Leucocytosis | 0.35 | ||
| Yes | 74.2 | 36.2–91.5 | |
| No | 96.0 | 74.8–99.4 | |
| Cytotoxic treatment | 0.28 | ||
| Yes | 84.6 | 55.1–95.4 | |
| No | 87.5 | 38.7–98.1 |
SF-Survivor function
CI-Confidence interval
p-value: for Log-Rank test
*
Log Rank for trend of SF (3 or more groups)